Flavia V Castelino Selected Research

Flavia V Castelino Research Topics

10	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 07/2009
6	Fibrosis (Cirrhosis) 12/2016 - 05/2011
4	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2021 - 01/2010
3	Connective Tissue Diseases (Connective Tissue Disease) 05/2021 - 01/2010
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2016 - 01/2010
2	Immunoglobulin G4-Related Disease 01/2022 - 01/2016
2	Infections 11/2021 - 12/2020
2	Diffuse Scleroderma (Progressive Systemic Sclerosis) 12/2020 - 01/2020
2	Neoplasms (Cancer) 01/2016 - 11/2012
2	Inflammation (Inflammations) 01/2016 - 11/2012
2	Disease Progression 11/2013 - 01/2010
1	Vasculitis (Vasculitides) 01/2022
1	general anxiety disorder 01/2022
1	Calcinosis 10/2020
1	Lung Diseases (Lung Disease) 11/2018
1	Lung Injury 01/2016
1	Rare Diseases (Rare Disease) 11/2013
1	Idiopathic Pulmonary Fibrosis 11/2012

3	lysophosphatidic acidIBA 12/2016 - 05/2011
3	Bleomycin (Blenoxane)FDA LinkGeneric 12/2016 - 05/2011
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 05/2021 - 05/2014
2	Abatacept (Orencia)FDA Link 12/2020 - 01/2020
2	LipidsIBA 12/2016 - 11/2012
2	PAT-048IBA 12/2016 - 01/2016
2	CytokinesIBA 01/2016 - 11/2014
2	Biomarkers (Surrogate Marker)IBA 11/2013 - 01/2010
2	Lysophosphatidic Acid ReceptorsIBA 11/2012 - 05/2011
1	N 30IBA 01/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	Rituximab (Mabthera)FDA Link 11/2021
1	nintedanibIBA 05/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	InterferonsIBA 01/2021
1	CalciumIBA 10/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2016
1	alkylglycerophosphoethanolamine phosphodiesteraseIBA 01/2016
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2016
1	Granzymes (Granzyme)IBA 01/2016
1	Pharmaceutical PreparationsIBA 11/2013
1	SphingolipidsIBA 11/2012
1	LysophospholipidsIBA 11/2012
1	EicosanoidsIBA 11/2012
1	Tyrosine Kinase InhibitorsIBA 07/2009
1	Imatinib Mesylate (Gleevec)FDA Link 07/2009

7	Therapeutics 11/2021 - 01/2010